Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anika Therapeutics (ANIK) Total Non-Current Liabilities: 2010-2025

Historic Total Non-Current Liabilities for Anika Therapeutics (ANIK) over the last 15 years, with Sep 2025 value amounting to -$761,000.

  • Anika Therapeutics' Total Non-Current Liabilities rose 5.58% to -$761,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$761,000, marking a year-over-year increase of 5.58%. This contributed to the annual value of -$772,000 for FY2024, which is 91.09% down from last year.
  • As of Q3 2025, Anika Therapeutics' Total Non-Current Liabilities stood at -$761,000, which was down 0.66% from -$756,000 recorded in Q2 2025.
  • In the past 5 years, Anika Therapeutics' Total Non-Current Liabilities ranged from a high of -$398,000 in Q4 2022 and a low of -$16.9 million during Q2 2021.
  • Over the past 3 years, Anika Therapeutics' median Total Non-Current Liabilities value was -$407,000 (recorded in 2024), while the average stood at -$568,545.
  • As far as peak fluctuations go, Anika Therapeutics' Total Non-Current Liabilities spiked by 96.53% in 2022, and later plummeted by 101.50% in 2024.
  • Anika Therapeutics' Total Non-Current Liabilities (Quarterly) stood at -$1.3 million in 2021, then spiked by 68.36% to -$398,000 in 2022, then decreased by 1.51% to -$404,000 in 2023, then slumped by 91.09% to -$772,000 in 2024, then increased by 5.58% to -$761,000 in 2025.
  • Its Total Non-Current Liabilities stands at -$761,000 for Q3 2025, versus -$756,000 for Q2 2025 and -$744,000 for Q1 2025.